Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications.
Looking for a particular Nanoform employee's phone or email?
The Nanoform annual revenue was $59 million in 2026.
Sami Svanbäck is the Co-founder of Nanoform.
129 people are employed at Nanoform.
Nanoform is based in Helsinki, Uusimaa.
The NAICS codes for Nanoform are [3254, 325, 32541, 32].
The SIC codes for Nanoform are [28, 283].